Recurrent Moderate-Severe Chronic Graft Versus Host Disease
specificThe reemergence of moderate-severe chronic graft versus host disease after a period of remission.
5
Centers
5
Active Trials
—
Cancer Funding
Top Centers for Recurrent Moderate-Severe Chronic Graft Versus Host Disease(5)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 60.0 |
| 2 | NCI Comprehensive Active Research Program | 60.0 |
| 3 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 60.0 |
| 4 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 60.0 |
| 5 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 60.0 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →